Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography

References

• Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354–1365.
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42:503–515.
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – updated June 2014. Endoscopy. 2014;46:799–815.
   PubMed Web of Science ®Google Scholar
• Joseph Elmunzer B, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414–1422.
   PubMed Web of Science ®Google Scholar
• Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405–432.
   PubMed Web of Science ®Google Scholar
• Ding X, Chen M, Huang S, et al. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2012;76:1152–1159.
   PubMed Web of Science ®Google Scholar
• Messman H, Vogt W, Hoistege A, et al. Post-ERCP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut. 1997;40:80–85.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5:132–144.
   PubMed Web of Science ®Google Scholar
• Probert L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience. 2015;302:2–22.
   PubMed Web of Science ®Google Scholar
• Mayer J, Rau B, Gansauge F, et al. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000;47:546–552.
   PubMed Web of Science ®Google Scholar
• Al Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. Wjg. 2008;14:675–684.
   PubMed Web of Science ®Google Scholar
• Yan Y, Guo TM, Zhu C. Effects of non-steroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of Ankylosing Spondylitis. Biochem Cell Biol 2018;96:450–456.
   PubMed Web of Science ®Google Scholar
• Yuan H, Jin X, Sun J, et al. Protective effect of HMGB1 a box on organ injury of acute pancreatitis in mice. Pancreas. 2009;38:143–148.
   PubMed Web of Science ®Google Scholar
• Luan ZG, Zhang XJ, Yin XH, et al. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis. Immunobiology. 2013;218:1261–1270.
   PubMed Web of Science ®Google Scholar
• Chirico V, Lacquaniti A, Salpietro V, et al. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside. Eur J Pediatr. 2014;173:1123–1136.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Zeh HJ, Rubartelli A, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 2007;220:60–81.
   PubMed Web of Science ®Google Scholar
• Kim JY, Park JS, Strassheim D, et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol. 2005;288:L958–L965.
   PubMed Web of Science ®Google Scholar
• Cao X, Wang HM, Du H, et al. Early predictors of hyperlipidemic acute pancreatitis. Exp Ther Med. 2018;16:4232–4238.
   PubMed Web of Science ®Google Scholar
• Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.
   PubMed Web of Science ®Google Scholar
• Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781–1788.
   PubMed Web of Science ®Google Scholar
• Li GD, Jia XY, Dong HY, et al. Pancreatic stent or rectal indomethacin-which better prevents post-ERCP pancreatitis? a propensity score matching analysis. Medicine (Baltimore). 2016;95:e2994.
   PubMed Web of Science ®Google Scholar
• Li L, Han Z, Yuan H, et al. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis. J Hepatobiliary Pancreat Sci. 2017;24:520–529.
   PubMed Web of Science ®Google Scholar
• Yuan L, Tang M, Huang L, et al. Risk factors of hyperglycemia in patients after a first episode of acute pancreatitis: a retrospective cohort. Pancreas. 2017;46:209–218.
   PubMed Web of Science ®Google Scholar
• Rashid N, Sharma PP, Scott RD, et al. Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system. J Clin Lipidol. 2016;10:880–890.
   PubMed Web of Science ®Google Scholar
• Albai O, Roman D, Frandes M. Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag. 2017;13:515–522.
   PubMed Web of Science ®Google Scholar
• Coté GA, Sagi SV, Schmidt SE, et al. Early measures of hemoconcentration and inflammation are predictive of prolonged hospitalization from post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2013;42:850–854.
   PubMed Web of Science ®Google Scholar
• Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines—new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology. 1993;40:522–530.
   PubMedGoogle Scholar
• Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190:117–125.
   PubMed Web of Science ®Google Scholar
• Karne S, Gorelick FS. Etiopathogenesis of acute pancreatitis. Surg Clin North Am. 1999;79:699–710.
   PubMed Web of Science ®Google Scholar
• Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 1997;100:1853–1862.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao HX, Bai C, et al. Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis. Sci Rep. 2017;7:6799.
   PubMed Web of Science ®Google Scholar
• Gao E, Jiang Y, Li Z, et al. Association between high mobility group box1 protein expression and cell death in acute pancreatitis. Mol Med Rep. 2017;15:e4021–e4026.
   PubMed Web of Science ®Google Scholar
• Luan ZG, Zhang H, Ma XC, et al. Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis. Pancreas. 2010;39:216–223.
   PubMed Web of Science ®Google Scholar
• Makela A, Kuusi T, Schroder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest. 1997;57:401–407.
   PubMed Web of Science ®Google Scholar
• Zhao XW, Bao JJ, Hu C, et al. Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis. Dig Dis Sci. 2014;59:2992–2996.
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Collier-Hyams LS, Young AN, et al. Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol. 2002;168:5260–5267.
   PubMed Web of Science ®Google Scholar